Syra Health Secures Population Health Contract Extension in Shelby County, Tennessee
CARMEL, Ind., February 25, 2025 /PRNewswire/ — Syra Health Corp. (NASDAQ: SYRA), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today a $450,000 contract extension with the Shelby County Health Department in Tennessee.
The one-year contract extension enables Syra Health’s team of epidemiologists and biostatisticians to continue uncovering disease trends and factors influencing disease while assessing their economic impact, as announced in February 2024. The project includes data analytics and the development of a public-facing dashboard to provide real-time insights and transparency. With an additional one-year renewal option in 2026, the total combined contract value over three years is up to $1.3 million.
This contract extension highlights the growth of Syra Health’s Population Health business unit, a key driver of the company’s revenue growth trajectory. The extension of this Population Health contract is in line with Syra Health’s strategy of diversifying revenue streams across higher-margin business units.
“The positive demand trends for our population health solutions showcase our ability to improve health outcomes,” said Dr. Deepika Vuppalanchi, chair and CEO of Syra Health. “As we expand our reach, we remain focused on ensuring long-term revenue growth and value creation.”
About Syra Health
Syra Health is a healthcare technology company powering better health in critical areas such as behavioral and mental health, population health, and the healthcare workforce. The company’s leading-edge technology and innovative services focus on prevention, access, and affordability. With a commitment to improving health, Syra Health is advancing healthcare solutions nationwide and around the world. For more information, please visit www.syrahealth.com.
Forward-Looking Statements
Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include but are not limited to, statements relating to the expected use of proceeds, the Company’s operations and business strategy, and the Company’s expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty, and changes in circumstances. Investors should read the risk factors set forth in our Form 10-K for the year ended December 31, 2023, and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.
Contacts
For Media Inquiries:
Christine Drury
Corporate Communications Director
Syra Health
463-345-5180
[email protected]
For Investor Inquiries:
Corbin Woodhull
Managing Director, Global Advisory
Hayden IR
602-476-1821
